Is there a liquid form of Clevatess?
Is there a liquid form of Clevatess available for patients who have difficulty swallowing tablets? Currently, Clevatess (pitavastatin and ezetimibe) is only manufactured and FDA-approved in tablet form, with no liquid formulation commercially available.
Available Clevatess Dosage Forms
Clevatess is exclusively produced as oral tablets in specific strength combinations. The medication combines two active ingredients:
- Pitavastatin (a statin for cholesterol reduction)
- Ezetimibe (a cholesterol absorption inhibitor)
Standard Tablet Strengths
The available tablet combinations include:
- 1 mg pitavastatin/10 mg ezetimibe
- 2 mg pitavastatin/10 mg ezetimibe
- 4 mg pitavastatin/10 mg ezetimibe
All formulations maintain the same 10 mg ezetimibe dose while varying the pitavastatin content based on patient needs.
Alternatives for Patients Unable to Swallow Tablets
For patients who cannot swallow Clevatess tablets whole, several options may be considered:
Tablet Modification
Some healthcare providers may recommend crushing or splitting tablets, though this should only be done under medical supervision. Not all medications are suitable for modification, and altering the tablet form can affect drug absorption and effectiveness.
Alternative Medications
Patients requiring liquid formulations might benefit from separate liquid versions of similar cholesterol medications, though this would require taking multiple medications instead of the convenient combination therapy that Clevatess provides.
Administration Techniques
Healthcare providers can suggest various techniques and tools to help patients swallow tablets more easily, including pill swallows aids and specific positioning methods.
Consulting Your Healthcare Provider
If you're having difficulty taking Clevatess tablets, discuss alternative approaches with your healthcare provider rather than attempting to modify the medication independently. Your doctor can evaluate whether Clevatess remains the best treatment option for your specific situation or if alternative cholesterol management strategies would be more appropriate.
Discussion (0)